117 related articles for article (PubMed ID: 11172899)
1. Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice.
Bex A; Wullich B; Endris V; Otto T; Rembrink K; Stöckle M; Rübben H
Cancer Genet Cytogenet; 2001 Jan; 124(2):98-104. PubMed ID: 11172899
[TBL] [Abstract][Full Text] [Related]
2. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
Hyytinen ER; Thalmann GN; Zhau HE; Karhu R; Kallioniemi OP; Chung LW; Visakorpi T
Br J Cancer; 1997; 75(2):190-5. PubMed ID: 9010025
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.
Lensch R; Götz C; Andres C; Bex A; Lehmann J; Zwergel T; Unteregger G; Kamradt J; Stoeckle M; Wullich B
Int J Oncol; 2002 Oct; 21(4):695-706. PubMed ID: 12239607
[TBL] [Abstract][Full Text] [Related]
4. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
5. Influence of linomide on local tumor growth and metastasis of the human hormone-resistant prostate cancer cell line PC3 in an orthotopic model.
Bex A; Luboldt H; Sudermann T; Rembrink K; Otto T; Rübben H
Eur Urol; 2000 May; 37(5):628-33. PubMed ID: 10765105
[TBL] [Abstract][Full Text] [Related]
6. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype.
Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS
Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801
[TBL] [Abstract][Full Text] [Related]
7. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW
Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003
[TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
9. Structural alterations of chromosome 5 in twelve human prostate cancer cell lines.
Ozen M; Navone NM; Multani AS; Troncoso P; Logothetis CJ; Chung LW; von Eschenbach AC; Pathak S
Cancer Genet Cytogenet; 1998 Oct; 106(2):105-9. PubMed ID: 9797773
[TBL] [Abstract][Full Text] [Related]
10. Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
Lin D; Bayani J; Wang Y; Sadar MD; Yoshimoto M; Gout PW; Squire JA; Wang Y
Prostate; 2010 Nov; 70(15):1636-44. PubMed ID: 20564316
[TBL] [Abstract][Full Text] [Related]
11. Reversion of human prostate tumorigenic growth by azatyrosine.
Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
[TBL] [Abstract][Full Text] [Related]
12. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
13. Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells.
Holleran JL; Miller CJ; Culp LA
J Histochem Cytochem; 2000 May; 48(5):643-51. PubMed ID: 10769048
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype.
Butterworth KT; McCarthy HO; Devlin A; Ming L; Robson T; McKeown SR; Worthington J
Int J Cancer; 2008 Aug; 123(4):760-8. PubMed ID: 18512241
[TBL] [Abstract][Full Text] [Related]
15. In vivo establishment and characterization of a paclitaxel-resistant human ovarian cancer cell line showing enhanced growth properties and drug-resistance only in vivo.
Okugawa K; Kobayashi H; Hirakawa T; Sonoda T; Ogura T; Nakano H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):178-86. PubMed ID: 14655049
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
17. New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.
Sakamoto S; Inoue H; Ohba S; Kohda Y; Usami I; Masuda T; Kawada M; Nomoto A
Cancer Sci; 2015 Apr; 106(4):367-74. PubMed ID: 25640943
[TBL] [Abstract][Full Text] [Related]
18. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations.
Karan D; Schmied BM; Dave BJ; Wittel UA; Lin MF; Batra SK
Clin Cancer Res; 2001 Nov; 7(11):3472-80. PubMed ID: 11705865
[TBL] [Abstract][Full Text] [Related]
19. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line.
Bae VL; Jackson-Cook CK; Maygarden SJ; Plymate SR; Chen J; Ware JL
Prostate; 1998 Mar; 34(4):275-82. PubMed ID: 9496902
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.
Marques RB; Erkens-Schulze S; de Ridder CM; Hermans KG; Waltering K; Visakorpi T; Trapman J; Romijn JC; van Weerden WM; Jenster G
Int J Cancer; 2005 Nov; 117(2):221-9. PubMed ID: 15900601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
